Literature DB >> 1427004

Prevalence of ompT among Escherichia coli isolates of human origin.

M D Lundrigan1, R M Webb.   

Abstract

OmpT is a protease associated with the outer membrane of Escherichia coli and possesses a high degree of homology to the plasminogen activator, Pla, of Yersinia pestis. We show here that OmpT from intact cells can indeed activate plasminogen. Clinical specimens of E. coli were examined for protease activity and for the ompT gene. Few isolates (12%) were found to be positive for OmpT activity, whereas most (77%) carried the ompT gene and expressed the cloned protease gene. In this report we present evidence suggesting that the surface architecture of E. coli influences the activity of OmpT and that OmpT may be indicative of the pathogenic potential of the organism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1427004     DOI: 10.1016/0378-1097(92)90362-r

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  13 in total

1.  Crystal structure of the outer membrane protease OmpT from Escherichia coli suggests a novel catalytic site.

Authors:  L Vandeputte-Rutten; R A Kramer; J Kroon; N Dekker; M R Egmond; P Gros
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

2.  Utilization of Escherichia coli outer-membrane endoprotease OmpT variants as processing enzymes for production of peptides from designer fusion proteins.

Authors:  Kazuaki Okuno; Masayuki Yabuta; Toshihiko Ooi; Shinichi Kinoshita
Journal:  Appl Environ Microbiol       Date:  2004-01       Impact factor: 4.792

3.  Immunoproteomic analysis to identify Shiga toxin-producing Escherichia coli outer membrane proteins expressed during human infection.

Authors:  David Montero; Paz Orellana; Daniela Gutiérrez; Daniela Araya; Juan Carlos Salazar; Valeria Prado; Angel Oñate; Felipe Del Canto; Roberto Vidal
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

4.  Evidence of commonality between canine and human extraintestinal pathogenic Escherichia coli strains that express papG allele III.

Authors:  J R Johnson; T T O'Bryan; D A Low; G Ling; P Delavari; C Fasching; T A Russo; U Carlino; A L Stell
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  Molecular epidemiologic approaches to urinary tract infection gene discovery in uropathogenic Escherichia coli.

Authors:  L Zhang; B Foxman; S D Manning; P Tallman; C F Marrs
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

6.  Cleavage of PGRP-LC receptor in the Drosophila IMD pathway in response to live bacterial infection in S2 cells.

Authors:  Rebecca L Schmidt; Francesca M Rinaldo; Shayla E Hesse; Masakazu Hamada; Zachary Ortiz; Daniah T Beleford; Andrea Page-McCaw; Jeffrey L Platt; Amy H Tang
Journal:  Self Nonself       Date:  2011-07-01

7.  Expression of the plague plasminogen activator in Yersinia pseudotuberculosis and Escherichia coli.

Authors:  V Kutyrev; R J Mehigh; V L Motin; M S Pokrovskaya; G B Smirnov; R R Brubaker
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

8.  Bacterial plasminogen receptors: in vitro evidence for a role in degradation of the mammalian extracellular matrix.

Authors:  K Lähteenmäki; R Virkola; R Pouttu; P Kuusela; M Kukkonen; T K Korhonen
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  Substrate specificity of the Escherichia coli outer membrane protease OmpT.

Authors:  John D McCarter; Daren Stephens; Kevin Shoemaker; Steve Rosenberg; Jack F Kirsch; George Georgiou
Journal:  J Bacteriol       Date:  2004-09       Impact factor: 3.490

10.  Identification of OmpT as the protease that hydrolyzes the antimicrobial peptide protamine before it enters growing cells of Escherichia coli.

Authors:  S Stumpe; R Schmid; D L Stephens; G Georgiou; E P Bakker
Journal:  J Bacteriol       Date:  1998-08       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.